Premium botulinum toxin type A clinically proven to reduce glabellar lines by 89% within 30 days (NCT00327158 Phase III trial). Formulated under FDA/EMA GMP standards with <2ng hemagglutinins and lactose-free stabilizers for enhanced biocompatibility. Delivers precise neuromuscular blockade for dynamic wrinkles, muscle spasms, and hyperhidrosis.

Proprietary Targeted Action Interface (TAI™) technology ensures precise neuromuscular blockade with ultra-focal 3.5nm diffusion radius (Clin Neuropharmacol. 2020). This molecular precision enables:
• Tissue-specific neurotoxin delivery
• Minimized diffusion to non-target areas
• Enhanced safety and efficacy profile

💊 Active: Clostridium botulinum type A neurotoxin (500U/vial)
📦 Presentation: Lyophilized powder in Type I glass vial
❄️ Storage: 2-8°C protected from light
📆 Shelf Life: 36 months unopened

Standard Dilution: 500U vial + 2.5mL 0.9% NaCl (200U/mL)
High Precision: 500U vial + 1.0mL NaCl (500U/mL)
Storage: Reconstituted solution stable ≤24hrs at 2-8°C
Dosing: Glabellar (20U-50U), Cervical dystonia (≥240U), Hyperhidrosis (100U/axilla), Limb spasticity (≤1000U total)

⚠️ Important Safety Notice: Contraindicated in hypersensitivity to botulinum toxins or neuromuscular disorders (myasthenia gravis, Eaton-Lambert syndrome). Not for use during pregnancy (Category C). For administration by licensed healthcare professionals only. Ipsen bears no responsibility for off-label use or improper injection techniques. Clinical results vary based on muscle mass, injection technique, and individual response. Report adverse events to FDA MedWatch.